Skip to main content
. 2019 Jun 6;21:138. doi: 10.1186/s13075-019-1917-8

Fig. 1.

Fig. 1

Kaplan-Meier retention curves in patients failing a csDMARDs and b a first bDMARD. bDMARD, biologic disease-modifying antirheumatic drug; csDMARD, conventional synthetic disease-modifying antirheumatic drug; TNFi, tumor necrosis factor inhibitor